Arbutus Biopharma Corp·4

Mar 5, 6:08 PM ET

Sofia Michael J. 4

4 · Arbutus Biopharma Corp · Filed Mar 5, 2019

Insider Transaction Report

Form 4
Period: 2019-03-01
Sofia Michael J.
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-03-01+145,000145,000 total
    Exercise: $4.57Exp: 2029-03-01Common Shares (145,000 underlying)
Footnotes (1)
  • [F1]The option will vest and become exercisable in three equal annual installments beginning March 1, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT